Yuichiro Eguchi - Concepedia

Author

Yuichiro Eguchi

Saga University ORCID

Also Known As

Eguchi Y, G Draganov, Hideki Fujii, JSG-NAFLD, Kento Imajo, Masafumi Ono, Y EGUCHI, Y Eguchi, Y. Eguchi, Y., Eguchi

362

Publications

15.1K

Citations

H-Index

114

Concepts

All Affiliations

Saga University Saga Medical School Hospital Kurume University Yokohama City University Osaka City University

About

Yuichiro Eguchi is an author at Saga University specializing in medicine, hepatology, and liver physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	46	3.7K
2	Health Sciences	19	24	2.6K
3	Public Health	9	9	640
4	Cell Biology	3	3	293
5	Biology	1	1	49

Yuichiro Eguchi

129

Publications

11K

Citations

H-Index

Page 1

	Year	Citations
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030 Chris Estes, Quentin M. Anstee, M. Arias, Journal of Hepatology	2018	1.9K
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates Zobair M. Younossi, Maria Stepanova, Janus P. Ong, Clinical Gastroenterology and Hepatology	2018	795
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography Kento Imajo, Takaomi Kessoku, Yasushi Honda, Gastroenterology	2015	784
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue, Journal of Hepatology FibrosisHepatologyLiver PhysiologyClinical TrialsPathology	2020	438
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population Yoshio Sumida, Masato Yoneda, Hideyuki Hyogo, BMC Gastroenterology ObesityMetabolic SyndromeMetabolic Associated SteatohepatitisBody CompositionHepatology	2012	376
Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease Yuichiro Eguchi, Takahisa Eguchi, Toshihiko Mizuta, Journal of Gastroenterology ObesityInsulin ResistanceMetabolic SyndromeMetabolic Associated SteatohepatitisHepatology	2006	269
Involvement of programmed cell death 4 in transforming growth factor-β1-induced apoptosis in human hepatocellular carcinoma Hao Zhang, Iwata Ozaki, Toshihiko Mizuta, Oncogene Tumor BiologyHuman Hepatocellular CarcinomaCell SignalingLiver PhysiologyApoptosis	2006	238
Evaluation of acoustic radiation force impulse elastography for fibrosis staging of chronic liver disease: a pilot study Naofumi Ono, Yuichiro Eguchi, Takahisa Eguchi, Liver International	2009	228
Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator‐activated receptor α modulator (SPPARMα), versus placebo in patients with non‐alcoholic fatty liver disease Atsushi Nakajima, Yuichiro Eguchi, Masato Yoneda, Alimentary Pharmacology & Therapeutics	2021	192
Pilot study of liraglutide effects in non‐alcoholic steatohepatitis and non‐alcoholic fatty liver disease with glucose intolerance in <scp>J</scp>apanese patients (<scp>LEAN</scp>‐<scp>J</scp>) Yuichiro Eguchi, Yoichiro Kitajima, Hideyuki Hyogo, Hepatology Research	2014	177

Page 1